Skip to search formSkip to main contentSkip to account menu

UCB 34714

Known as: UCB-34714, UCB34714 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Brivaracetam

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Progress report on new antiepileptic drugs: A summary of the Eleventh Eilat Conference (EILAT XI)
Highly Cited
2011
Highly Cited
2011
Brivaracetam (UCB 34714)
Highly Cited
2010
Highly Cited
2010
Brivaracetam (ucb 34714) inhibits Na+ current in rat cortical neurons in culture
Highly Cited
2008
Highly Cited
2008
Anti‐convulsive and anti‐epileptic properties of brivaracetam (ucb 34714), a high‐affinity ligand for the synaptic vesicle protein, SV2A
Screening of 12 000 compounds for binding affinity to the synaptic vesicle protein 2A (SV2A), identified a high‐affinity… 
2008
2008
Brivaracetam: a new drug in development for epilepsy and neuropathic pain
Background: Epilepsy is a neurological disorder with a worldwide prevalence estimated to be 0.5 – 1.0% of the population. Many… 
Review
2007
Review
2007
Brivaracetam (UCB 34714).
Brivaracetam (UCB 34714) is chemically related to levetiracetam (LEV, Keppra). It possesses a binding affinity for the synaptic… 
Review
2006
Review
2006
New antiepileptic drugs that are second generation to existing antiepileptic drugs
  • M. Bialer
  • Expert Opinion on Investigational Drugs
  • 2006
  • Corpus ID: 21166138
In the last decade, 10 new antiepileptic drugs (AEDs) have been introduced that offer appreciable advantages in terms of their… 
Review
2005
Review
2005
Brivaracetam UCB.
Brivaracetam (UCB-34714), an orally active, high-affinity synaptic vesicle protein 2A ligand, is being developed by UCB for the… 
Review
2004
Review
2004
Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)
Highly Cited
2004
Highly Cited
2004
Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity.
(S)-alpha-ethyl-2-oxopyrrolidine acetamide 2 (levetiracetam, Keppra, UCB S.A.), a structural analogue of piracetam, has recently… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)